## Physiologic Cardiac Hypertrophy in Pregnancy This question tests understanding of **physiologic (adaptive) hypertrophy and hyperplasia** — a normal, reversible cellular adaptation distinct from pathologic hypertrophy. ### Pathophysiology of Pregnancy-Induced Cardiac Changes **Key Point:** Pregnancy induces a unique pattern of cardiac remodeling characterized by: 1. **Eccentric hypertrophy** (increase in both wall thickness AND chamber diameter) 2. **Increased cardiac output** (30–50% above baseline by third trimester) 3. **Increased plasma volume** (40–50% expansion) 4. **Decreased systemic vascular resistance** (due to placental vasculature and hormonal effects) **High-Yield:** The stimulus is physiologic (hemodynamic load from increased blood volume and cardiac output), not pathologic (no ischemia, inflammation, or genetic defect). The adaptation is **fully reversible** within 6–12 weeks postpartum. ### Comparison: Physiologic vs. Pathologic Hypertrophy | Feature | Physiologic (Pregnancy) | Pathologic (HTN/Aortic Stenosis) | |---------|------------------------|----------------------------------| | **Trigger** | Increased preload + decreased afterload | Increased afterload (pressure overload) | | **Pattern** | Eccentric (↑ wall + ↑ cavity) | Concentric (↑ wall, normal/↓ cavity) | | **Contractility** | Preserved or enhanced | Initially preserved, then ↓ | | **Diastolic function** | Normal | Impaired (restrictive pattern) | | **Reversibility** | Complete (postpartum) | Partial (if stimulus removed) | | **Prognosis** | Excellent; no intervention needed | Requires treatment of underlying cause | **Mnemonic: PREP** — **P**hysiologic, **R**eversible, **E**ccentric, **P**ostpartum regression ### Management Algorithm for Cardiac Changes in Pregnancy ```mermaid flowchart TD A[Pregnant patient with cardiac enlargement]:::outcome --> B{Symptoms of heart failure?}:::decision B -->|No| C{EF preserved?}:::decision B -->|Yes| D[Assess for peripartum cardiomyopathy]:::action C -->|Yes| E[Reassure: physiologic adaptation]:::action C -->|No| F[Investigate for pathologic cardiomyopathy]:::action E --> G[Routine antenatal care + postpartum echo]:::action D --> H[Echocardiography + troponin + BNP]:::action F --> I[Cardiac MRI ± biopsy]:::action ``` **Clinical Pearl:** Peripartum cardiomyopathy (PPCM) is a **pathologic** form of dilated cardiomyopathy that presents in the last month of pregnancy or first 5 months postpartum with **systolic dysfunction** (EF <45%) and symptoms of heart failure. This patient has: - Preserved ejection fraction (implied by normal wall motion) - No symptoms of heart failure - Normal fetal growth (no placental insufficiency) These findings are **inconsistent with PPCM** and point to benign physiologic adaptation. **Key Point:** The absence of symptoms, preserved EF, and normal fetal growth make this a straightforward case of physiologic cardiac adaptation. No pharmacotherapy is indicated. The patient should be reassured and followed with routine antenatal care and a postpartum echocardiogram (6–8 weeks after delivery) to document regression. [cite:Robbins 10e Ch 1; Harrison 21e Ch 242; Williams Obstetrics 25e Ch 4] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.